Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection

Overview

Journal J Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2016 Aug 31

PMID 27571902

Citations 11

Authors

Arnold Reynaldi

Timothy E Schlub

Erwan Piriou

Sidney Ogolla

Odada P Sumba

Ann M Moormann

Rosemary Rochford

Miles P Davenport

Affiliations

Soon will be listed here.

Abstract

The combination of Epstein-Barr virus (EBV) infection and high malaria exposure are risk factors for endemic Burkitt lymphoma, and evidence suggests that infants in regions of high malaria exposure have earlier EBV infection and increased EBV reactivation. In this study we analyzed the longitudinal antibody response to EBV in Kenyan infants with different levels of malaria exposure. We found that high malaria exposure was associated with a faster decline of maternally derived immunoglobulin G antibody to both the EBV viral capsid antigen and EBV nuclear antigen, followed by a more rapid rise in antibody response to EBV antigens in children from the high-malaria-transmission region. We also observed the long-term persistence of anti-viral capsid antigen immunoglobulin M responses in children from the high-malaria region. More rapid decay of maternal antibodies was a major predictor of EBV infection outcome, because decay predicted time to EBV DNA detection, independent of high or low malaria exposure.

Citing Articles

Maternal F1 antibodies and cytokines in mother-neonate dog pairs in the plague focus.

Tang D, Bukai A, Qin S, Duan R, Lyu D, He Z Heliyon. 2025; 11(3):e42336.

PMID: 39991224 PMC: 11847103. DOI: 10.1016/j.heliyon.2025.e42336.

Epstein-Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992-2008.

Sabourin K, Mugisha J, Asiki G, Nalwoga A, Labo N, Miley W Infect Agent Cancer. 2023; 18(1):55.

PMID: 37775773 PMC: 10543268. DOI: 10.1186/s13027-023-00534-7.

How Does Epstein-Barr Virus Interact With Other Microbiomes in EBV-Driven Cancers?.

Wen Y, Xu H, Han J, Jin R, Chen H Front Cell Infect Microbiol. 2022; 12:852066.

PMID: 35281433 PMC: 8904896. DOI: 10.3389/fcimb.2022.852066.

HIV-exposed infants with EBV infection have a reduced persistence of the immune response to the HBV vaccine.

Baroncelli S, Galluzzo C, Liotta G, Andreotti M, Orlando S, Ciccacci F AIDS Res Ther. 2021; 18(1):48.

PMID: 34348748 PMC: 8336389. DOI: 10.1186/s12981-021-00375-7.

Studies and Clinical Observations Imply a Synergistic Effect Between Epstein-Barr Virus and Dengue Virus Infection.

Deng X, Zhao L, Liang X, Li D, Yu L, Zhang F Front Microbiol. 2021; 12:691008.

PMID: 34220783 PMC: 8249608. DOI: 10.3389/fmicb.2021.691008.

References

Moormann A, Chelimo K, Sumba O, Lutzke M, Ploutz-Snyder R, Newton D . Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis. 2005; 191(8):1233-8. DOI: 10.1086/428910. View

Chan K, Tam J, Peiris J, Seto W, Ng M . Epstein-Barr virus (EBV) infection in infancy. J Clin Virol. 2001; 21(1):57-62. DOI: 10.1016/s1386-6532(01)00149-4. View

Piriou E, Kimmel R, Chelimo K, Middeldorp J, Odada P, Ploutz-Snyder R . Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med Virol. 2009; 81(6):1088-93. PMC: 3134942. DOI: 10.1002/jmv.21485. View

Carpenter L, Newton R, Casabonne D, Ziegler J, Mbulaiteye S, Mbidde E . Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer. 2007; 122(6):1319-23. DOI: 10.1002/ijc.23254. View

Morrison B, Labo N, Miley W, Whitby D . Serodiagnosis for tumor viruses. Semin Oncol. 2015; 42(2):191-206. PMC: 4387312. DOI: 10.1053/j.seminoncol.2014.12.024. View

Moormann A, Chelimo K, Sumba P, Tisch D, Rochford R, Kazura J . Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis. 2007; 195(6):799-808. DOI: 10.1086/511984. View

Asito A, Piriou E, Odada P, Fiore N, Middeldorp J, Long C . Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study. Infect Agent Cancer. 2010; 5:13. PMC: 2923120. DOI: 10.1186/1750-9378-5-13. View

Daud I, Ogolla S, Amolo A, Namuyenga E, Simbiri K, Bukusi E . Plasmodium falciparum infection is associated with Epstein-Barr virus reactivation in pregnant women living in malaria holoendemic area of Western Kenya. Matern Child Health J. 2014; 19(3):606-14. PMC: 4272914. DOI: 10.1007/s10995-014-1546-4. View

Lamy M, Favart A, Cornu C, Mendez M, Segas M, Burtonboy G . Study of Epstein Barr virus (EBV) antibodies: IgG and IgM anti-VCA, IgG anti-EA and Ig anti-EBNA obtained with an original microtiter technique: --serological criterions of primary and recurrent EBV infections and follow-up of infectious.... Acta Clin Belg. 1982; 37(5):281-98. DOI: 10.1080/22953337.1982.11718879. View

10.

Muller T, Gicklhorn D, Jungraithmayr T, Eickmann M, Lange H, Radsak K . Pattern and persistence of the epitope-specific IgM response against human cytomegalovirus in renal transplant patients. J Clin Virol. 2001; 24(1-2):45-56. DOI: 10.1016/s1386-6532(01)00228-1. View

11.

Okoko B, Wesumperuma L, Ota M, Pinder M, Banya W, Gomez S . The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population. J Infect Dis. 2001; 184(5):627-32. DOI: 10.1086/322808. View

12.

Geser A, Day N, Tukei P, Williams E, Beri D, Smith P . Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature. 1978; 274(5673):756-61. DOI: 10.1038/274756a0. View

13.

Evans A, Niederman J, Cenabre L, West B, Richards V . A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. J Infect Dis. 1975; 132(5):546-54. DOI: 10.1093/infdis/132.5.546. View

14.

Fleisher G, Henle W, Henle G, Lennette E, Biggar R . Primary infection with Epstein-Barr virus in infants in the United States: clinical and serologic observations. J Infect Dis. 1979; 139(5):553-8. DOI: 10.1093/infdis/139.5.553. View

15.

Fachiroh J, Paramita D, Hariwiyanto B, Harijadi A, Dahlia H, Indrasari S . Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for.... J Clin Microbiol. 2006; 44(4):1459-67. PMC: 1448657. DOI: 10.1128/JCM.44.4.1459-1467.2006. View

16.

Meyohas M, Marechal V, Desire N, Bouillie J, FROTTIER J, Nicolas J . Study of mother-to-child Epstein-Barr virus transmission by means of nested PCRs. J Virol. 1996; 70(10):6816-9. PMC: 190727. DOI: 10.1128/JVI.70.10.6816-6819.1996. View

17.

Cohen J . Epstein-Barr virus infection. N Engl J Med. 2000; 343(7):481-92. DOI: 10.1056/NEJM200008173430707. View

18.

Biggar R, Henle W, Fleisher G, Bocker J, Lennette E, Henle G . Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer. 1978; 22(3):239-43. DOI: 10.1002/ijc.2910220304. View

19.

Reynaldi A, Schlub T, Chelimo K, Sumba P, Piriou E, Ogolla S . Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children. J Infect Dis. 2015; 213(6):985-91. PMC: 4760420. DOI: 10.1093/infdis/jiv525. View

20.

Robertson P, Beynon S, Whybin R, Brennan C, Vollmer-Conna U, Hickie I . Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. J Med Virol. 2003; 70(4):617-23. DOI: 10.1002/jmv.10439. View